SCHEMBL10201092

SCHEMBL10201092

CO[C@H]1CCCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL84554 1.00
SCHEMBL9969577 1.00
Bromide SCHEMBL9248120 0.97
SCHEMBL13412378 0.97
SCHEMBL300796 0.92
SCHEMBL8440543 0.91 ALDH1A1 (0.35)
Benzene SCHEMBL9215717 0.89 SLC6A3 (0.40)
Tetrahydrofuran SCHEMBL8438362 0.88 ALDH1A1 (0.36)
SCHEMBL838994 0.83
Allyl Alcohol SCHEMBL27901565 0.82 PTPN1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4169924-A2 SYNTHESIS OF HALICHONDRINS President And Fellows Of Harvard College (US) 2023-04-26 EP disclosed
US-9353218-B2 Kit for multifunctional compounds forming crosslinked biomaterials ANGIOTECH PHARMACEUTICALS, INC. 2016-05-31 US disclosed
US-9353218-B2 Kit for multifunctional compounds forming crosslinked biomaterials ANGIOTECH PHARMACEUTICALS, INC. 2016-05-31 US disclosed
US-8841092-B2 Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-09-23 US disclosed
US-20130289235-A1 MULTIFUNCTIONAL COMPOUNDS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE ANGIOTECH PHARMACEUTICALS, INC. (CA) 2013-10-31 US disclosed
US-20130289235-A1 MULTIFUNCTIONAL COMPOUNDS FOR FORMING CROSSLINKED BIOMATERIALS AND METHODS OF PREPARATION AND USE ANGIOTECH PHARMACEUTICALS, INC. (CA) 2013-10-31 US disclosed
US-20130224276-A1 COMPOSITIONS AND METHODS FOR COATING MEDICAL IMPLANTS ANGIOTECH INTERNATIONAL AG (CH) 2013-08-29 US disclosed
US-20130224276-A1 COMPOSITIONS AND METHODS FOR COATING MEDICAL IMPLANTS ANGIOTECH INTERNATIONAL AG (CH) 2013-08-29 US disclosed
US-8486437-B2 Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use ANGIOTECH PHARMACEUTICALS (US), INC. (US) 2013-07-16 US disclosed
US-8486437-B2 Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use ANGIOTECH PHARMACEUTICALS (US), INC. (US) 2013-07-16 US disclosed
US-20070196421-A1 Soft tissue implants and drug combination compositions, and use thereof ANGIOTECH INTERNATIONAL AG (CH) 2007-08-23 US disclosed
US-20070196421-A1 Soft tissue implants and drug combination compositions, and use thereof ANGIOTECH INTERNATIONAL AG (CH) 2007-08-23 US disclosed
US-20070198063-A1 Electrical devices and anti-scarring drug combinations HUNTER WILLIAM L 2007-08-23 US disclosed
WO-2007089878-A2 SUTURES AND ANTI-SCARRING AGENTS ANGIOTECH PHARMACEUTICALS, INC. (CA) 2007-08-09 WO disclosed
US-7241736-B2 spider, silkworm or other silk as a fibrosing agent; induce adhesion or fibrosis in the walls of the diverticula or facilitate \"filling\" of the diverticula in situ; thus obliterating the lumen of the diverticula and relieving symptoms ANGIOTECH INTERNATIONAL AG (CH) 2007-07-10 US disclosed
US-7241736-B2 spider, silkworm or other silk as a fibrosing agent; induce adhesion or fibrosis in the walls of the diverticula or facilitate \"filling\" of the diverticula in situ; thus obliterating the lumen of the diverticula and relieving symptoms ANGIOTECH INTERNATIONAL AG (CH) 2007-07-10 US disclosed
WO-2007041677-A9 SOFT TISSUE IMPLANTS AND DRUG COMBINATION COMPOSITIONS, AND USE THEREOF COMBINATORX INC (US) 2007-05-31 WO disclosed
WO-2007041463-A2 ELECTRICAL DEVICES AND ANTI-SCARRING DRUG COMBINATIONS COMBINATORX, INCORPORATED (US) 2007-04-12 WO disclosed
US-7166570-B2 Treating varicose or veins by injecting a composition silk made of polyalkylene oxide-polyester block copolymer into the lumen of a vein; anchoring implantable medical devices into or onto biological tissue ANGIOTECH INTERNATIONAL AG (CH) 2007-01-23 US disclosed
US-7166570-B2 Treating varicose or veins by injecting a composition silk made of polyalkylene oxide-polyester block copolymer into the lumen of a vein; anchoring implantable medical devices into or onto biological tissue ANGIOTECH INTERNATIONAL AG (CH) 2007-01-23 US disclosed